First Time Loading...

Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436

Watchlist Manager
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Logo
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Watchlist
Price: 237.85 CNY -0.52% Market Closed
Updated: May 12, 2024

Wall Street
Price Targets

Price Targets Summary
Zhangzhou Pientzehuang Pharmaceutical Co Ltd

Wall Street analysts forecast Zhangzhou Pientzehuang Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Zhangzhou Pientzehuang Pharmaceutical Co Ltd is 291.33 CNY with a low forecast of 191.9 CNY and a high forecast of 344.4 CNY.

Lowest
Price Target
191.9 CNY
19% Downside
Average
Price Target
291.33 CNY
22% Upside
Highest
Price Target
344.4 CNY
45% Upside
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Competitors:
Price Targets
6600
SciClone Pharmaceuticals (Holdings) Ltd
0% Upside
PFE
Pfizer Inc
14% Upside
CARA
Cara Therapeutics Inc
608% Upside
PFIZER
Pfizer Ltd
7% Upside
CAPLIPOINT
Caplin Point Laboratories Ltd
27% Upside
506260
Anuh Pharma Ltd
25% Upside
688185
CanSino Biologics Inc
38% Upside
2186
Luye Pharma Group Ltd
2% Upside

Revenue
Forecast

Revenue Estimate
Zhangzhou Pientzehuang Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's revenue is 25%. The projected CAGR for the next 4 years is 15%.

25%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Zhangzhou Pientzehuang Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's operating income is 26%. The projected CAGR for the next 4 years is 28%.

26%
Past Growth
28%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Zhangzhou Pientzehuang Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's net income is 24%. The projected CAGR for the next 3 years is 20%.

24%
Past Growth
20%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's stock price target?
Price Target
291.33 CNY

According to Wall Street analysts, the average 1-year price target for Zhangzhou Pientzehuang Pharmaceutical Co Ltd is 291.33 CNY with a low forecast of 191.9 CNY and a high forecast of 344.4 CNY.

What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
15%

For the last 8 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's revenue is 25%. The projected CAGR for the next 4 years is 15%.

What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
28%

For the last 8 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's operating income is 26%. The projected CAGR for the next 4 years is 28%.

What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
20%

For the last 8 years the compound annual growth rate for Zhangzhou Pientzehuang Pharmaceutical Co Ltd's net income is 24%. The projected CAGR for the next 3 years is 20%.